Results 171 to 180 of about 1,957,788 (244)

Watercolours of New Zealand subjects [2] [picture] /

open access: yes
Also available in an electronic version via the Internet at: http://nla.gov.au/nla.pic-an10543540 ...
Male, R., Rev.
core  

A real‐world analysis of AI chatbot performance for medicines information enquiries

open access: yesJournal of Pharmacy Practice and Research, EarlyView.
Abstract Background The provision of medicines information (MI) services requires interpretation and clinical judgement of complex scenarios by pharmacists. To date, few studies have assessed the performance of artificial intelligence (AI) chatbots to assist pharmacists providing MI advice.
Duncan Yorkston   +2 more
wiley   +1 more source

Watercolours of New Zealand subjects [7] [picture] /

open access: yes
Also available in an electronic version via the Internet at: http://nla.gov.au/nla.pic-an10543540 ...
Male, R., Rev.
core  

Raising the bar: Utilizing quality improvement tools to increase compliance with clinical care guidelines in inflammatory bowel disease patients

open access: yesJPGN Reports, EarlyView.
Abstract Patients admitted for inflammatory bowel disease (IBD) are often managed by rotating teams of care providers during their hospital stay. This can lead to potential variability in the care they receive. Our team developed a scoring system of six key high‐quality care components called the standardized IBD care index (SICI) to standardize care ...
Amir Jazayeri   +4 more
wiley   +1 more source

Watercolours of New Zealand subjects [3] [picture] /

open access: yes
Also available in an electronic version via the Internet at: http://nla.gov.au/nla.pic-an10543540 ...
Male, R., Rev.
core  

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan   +2 more
wiley   +1 more source

Adding a Prevention Intervention to an Established App: The Blued+ HIV Prevention Pilot Study in Beijing and Chengdu, China. [PDF]

open access: yesJ Int AIDS Soc
Siegler AJ   +10 more
europepmc   +1 more source

Pediatric hereditary angioedema presenting as recurrent episodic abdominal pain and vomiting: Challenges in diagnosis and management

open access: yesJPGN Reports, EarlyView.
Abstract Recurrent episodic abdominal pain and vomiting, with symptom‐free intervals between attacks, represent common and often challenging presentations in children, typically leading to extensive workups without a clear etiology, as standard diagnostic algorithms fail to include rare systemic conditions. We present the challenging diagnostic odyssey
Julio Nestor Busaniche   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy